Clinical implication of targeting of cancer stem cells.
The existence of cancer stem cells (CSCs) is receiving increasing interest particularly due to its potential ability to enter clinical routine. Rapid advances in the CSC field have provided evidence for the development of more reliable anticancer therapies in the future. CSCs typically only constitute a small fraction of the total tumor burden; however, they harbor self-renewal capacity and appear to be relatively resistant to conventional therapies. Recent therapeutic approaches aim to eliminate or differentiate CSCs or to disrupt the niches in which they reside. Better understanding of the biological characteristics of CSCs as well as improved preclinical and clinical trials targeting CSCs may revolutionize the treatment of many cancers.
Department of Surgery, Munich Medical Center, Campus Grosshadern, LMU Munich, Munich, Germany. Lu.Zhao@med.uni-muenchen.de
L
L
Zhao
Y
Y
Zhao
Q
Q
Bao
H
H
Niess
K-W
KW
Jauch
C J
CJ
Bruns
D000970:Antineoplastic Agents / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000528:radiation effects; D047368:Tumor Burden
D000970:Antineoplastic Agents